{"key":"op_713_DE","page":{"url":"https://ru.bookimed.com/clinics/country=germany/procedure=immunoterapia-pri-rake-grudi/","procedure":{"id":713,"slug":"immunoterapia-pri-rake-grudi","name":"Иммунотерапия при раке груди","name_forms":{"plural":{"status":"missing","reason":"not_collected"},"genitive":{"status":"missing","reason":"not_collected"}},"type":"therapy","grammar_number":{"status":"missing","reason":"not_collected"},"parent_id":"oncology","family_attribute":{"status":"missing","reason":"not_collected"}},"country":{"id":22,"iso":"DE","name":"Германия"},"currency":"USD","data_date":"2026-10-02"},"pages":{"clinics_url":"https://ru.bookimed.com/clinics/country=germany/procedure=immunoterapia-pri-rake-grudi/","cost_url":"https://ru.bookimed.com/clinics/country=germany/procedure=immunoterapia-pri-rake-grudi/cost/","best_url":{"status":"missing","reason":"template not live"}},"price":{"from":14000,"to":30000,"avg":{"status":"missing","reason":"no_offers"},"us":{"from":60000,"to":150000},"uk":{"from":24000,"to":48000},"by_technique":{"status":"missing","reason":"not_collected"},"by_city":[{"city":"Гамбург","from":18200},{"city":"Бремен","from":9200},{"city":"Берлин","from":6500}],"per_unit":{"status":"missing","reason":"not_collected"},"factors":{"status":"missing","reason":"not_collected"},"tiers":{"status":"missing","reason":"no_offers"},"comparison":[{"country_iso":"UA","from":6500,"to":15000},{"country_iso":"FR","from":14000,"to":30000},{"country_iso":"GB","from":24000,"to":48000},{"country_iso":"US","from":60000,"to":150000},{"country_iso":"IL","from":28000,"to":48000},{"country_iso":"TR","from":8000,"to":16000},{"country_iso":"MX","from":12000,"to":25000},{"country_iso":"CA","from":28000,"to":65000},{"country_iso":"AE","from":30000,"to":65000},{"country_iso":"TH","from":5900,"to":14000},{"country_iso":"PL","from":6500,"to":13500},{"country_iso":"KR","from":14000,"to":27000},{"country_iso":"CZ","from":9000,"to":20000},{"country_iso":"AT","from":18000,"to":36000},{"country_iso":"ES","from":2200,"to":28000},{"country_iso":"IT","from":18000,"to":34000},{"country_iso":"CN","from":14000,"to":36000},{"country_iso":"AU","from":16000,"to":29000},{"country_iso":"IN","from":14000,"to":23000},{"country_iso":"MY","from":14000,"to":30000},{"country_iso":"VN","from":14000,"to":27000},{"country_iso":"BR","from":9000,"to":20000}],"base_country":"US","base_is_fallback":false},"savings":{"pct":77,"variant":">=15%"},"package":{"included":{"status":"missing","reason":"no_offers"},"excluded":{"status":"missing","reason":"no_offers"},"extra_charges":{"status":"missing","reason":"not_collected"}},"clinics":{"count":3,"items":[{"id":136,"name":"Nordwest Clinic (Krankenhaus)","city":"Frankfurt am Main","rating":4.5,"reviews_count":57,"accreditations":["TÜV AG Company Research & Investing Certificate","TOP German hospital according to 2019 Focus ranking","World's Best Hospitals 2021 by Newsweek"],"rank":1,"has_procedure":true,"why_ranked":"Center for Oncology and Hematology is ESMO-certified, one of only 22 globally. Professor Elke Jaeger conducts research in individualized cancer vaccines and has performed 1,100+ procedures.","bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":29,"name":"Charité - Universitätsmedizin Berlin","city":"Berlin","rating":3.3,"reviews_count":3,"accreditations":["German Cancer Society","TOP German hospital according to 2019 Focus ranking","World's Best Hospitals 2021 by Newsweek","World's Best Hospitals 2022 by Newsweek","World's Best Smart Hospitals 2023 by Newsweek"],"rank":2,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}},{"id":404,"name":"Bremen-Ost Clinic","city":"Bremen","rating":{"status":"missing","reason":"not_collected"},"reviews_count":{"status":"missing","reason":"not_collected"},"accreditations":["Cooperation for transparency and quality in the health service","TOP German hospital according to 2019 Focus ranking"],"rank":3,"has_procedure":true,"why_ranked":{"status":"missing","reason":"not_collected"},"bookimed_stats":{"status":"missing","reason":"not_published"},"procedure_description":{"status":"missing","reason":"not_collected"},"offers":{"status":"missing","reason":"no_offers"}}]},"doctors":{"count":4,"languages":{"status":"missing","reason":"not_collected"}},"cities":[{"id":119,"slug":"gamburg","name":"Гамбург","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":18200,"profile":{"city_type":"Second-largest city in Germany","access":["Hamburg Airport (HAM), 9 km north of city center"],"sources":["https://en.wikipedia.org/wiki/Hamburg","https://en.wikipedia.org/wiki/Hamburg_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":352,"slug":"bremen","name":"Бремен","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":9200,"profile":{"city_type":"Hanseatic port city in northern Germany","access":["Bremen Airport (BRE), 4 km south of the city"],"sources":["https://en.wikipedia.org/wiki/Bremen","https://en.wikipedia.org/wiki/Bremen_Airport"],"checked_at":"2026-11-03","status":"ok"}},{"id":23,"slug":"berlin","name":"Берлин","clinics_count":{"status":"missing","reason":"not_collected"},"price_from":6500,"profile":{"city_type":"Capital and largest city of Germany","access":["Berlin Airport (BER), 18 km from the city center"],"sources":["https://en.wikipedia.org/wiki/Berlin","https://en.wikipedia.org/wiki/Berlin_Brandenburg_Airport"],"checked_at":"2026-11-03","status":"ok"}}],"offers":{"active":{"status":"missing","reason":"no_offers"},"active_with_related":{"status":"missing","reason":"no_offers"},"hospital_nights_median":{"status":"missing","reason":"no_offers"},"days_in_country_median":{"status":"missing","reason":"no_offers"},"top_offers":{"status":"missing","reason":"no_offers"},"packages":{"status":"missing","reason":"no_offers"},"related_packages":{"status":"missing","reason":"no_offers"},"other_packages":{"status":"missing","reason":"no_offers"}},"medical":{"indications":["High-risk stage II-III early triple-negative breast cancer, with chemotherapy","Metastatic PD-L1-positive triple-negative breast cancer, with chemotherapy"],"contraindications":["Active autoimmune disease requiring systemic immunosuppression","History of organ transplant","Prior severe immune-related adverse event","Active uncontrolled infection","Pregnancy or breastfeeding","History of interstitial lung disease or pneumonitis","Long-term high-dose corticosteroid use"],"operation_hours":{"min":2,"max":6,"unit":"hours","qualifier":"Per visit; longer when combined with chemotherapy and pre-infusion tests."},"anesthesia":["none"],"sessions_or_stages":{"sessions":{"min":9,"max":17,"unit":"visits","qualifier":"Infusions every 3-6 weeks for about a year, usually with chemotherapy."},"stages":[{"code":"neoadjuvant","label":"Immunotherapy with chemotherapy before surgery","after":{"min":0,"max":168,"unit":"days","qualifier":"About 5.5 months of combined cycles."}},{"code":"surgery","label":"Surgery at home or local center","after":{"min":170,"max":210,"unit":"days","qualifier":"Timing set by treating oncology team."}},{"code":"adjuvant","label":"Adjuvant immunotherapy continuation","after":{"min":220,"max":365,"unit":"days","qualifier":"Continues up to about a year in total."}}],"qualifier":"Typical early high-risk triple-negative protocol; later cycles often continue at home."},"hospital_nights":{"value":{"min":0,"max":0,"unit":"nights","qualifier":"Infusions are given as outpatient visits without overnight stay."},"source":"parsed_details"},"treatment_conditions":["outpatient"],"rehabilitation_days":{"status":"missing","reason":"not_collected"},"fly_home_after_days":{"min":1,"max":3,"unit":"days","qualifier":"Depends on infusion reactions and chemotherapy blood counts."},"back_to_work_days":{"min":2,"max":7,"unit":"days","qualifier":"Fatigue after infusion and concurrent chemotherapy often limit work; many patients work part-time."},"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity as tolerated; intensity depends on fatigue and chemotherapy side effects."},"final_result_months":{"min":6,"max":12,"unit":"months","qualifier":"Response assessed after neoadjuvant phase and surgery; full course lasts about a year."},"result_longevity":"Benefit duration varies; in responders, immune-mediated disease control can persist for years after treatment ends.","main_risks":["Immune-related organ inflammation; some severe or permanent.","Infusion reactions are possible with some agents.","Added toxicity when combined with chemotherapy."],"complication_rate_pct":{"min":60,"max":80,"unit":"percent","qualifier":"Grade 3-4 adverse events including chemotherapy toxicity; immune-related events of grade 3+ about 10-15%."},"revision_rate_pct":{"status":"missing","reason":"not_collected"},"success":{"metric":"Event-free survival at 5 years","value":81,"horizon":"5 years","source":{"status":"missing","reason":"not_collected"},"evidence_status":"proven"},"scars":"None; no incisions.","pain":"Infusion causes only cannula discomfort. Fatigue, joint aches or rash may occur; combined chemotherapy adds further discomfort.","preparation":["Confirm receptor status and PD-L1 result","Baseline blood, liver, thyroid and cortisol tests","Baseline imaging","Review autoimmune and transplant history","Screen for infections such as hepatitis","Pregnancy test if applicable"],"recovery_timeline":[{"phase":"Infusion day","description":"Infusion lasts 30-60 minutes for immunotherapy, longer with chemotherapy; monitored for reactions.","restrictions":["Report fever, breathlessness or rash promptly"]},{"phase":"Days 1-7 after infusion","description":"Fatigue, nausea and mild flu-like symptoms are common, mainly from chemotherapy.","restrictions":["Avoid crowds if blood counts are low"]},{"phase":"Months 1-12","description":"Cycles repeat every 3-6 weeks; immune-related effects may appear at any time, even after completion.","restrictions":["Do not start new medicines without oncologist approval"]}],"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":21,"max":42,"unit":"days","qualifier":"Blood, thyroid and liver tests before each cycle to detect immune-related effects."}},{"purpose":"result_review","requirement":"routine","after":{"min":84,"max":126,"unit":"days","qualifier":"Imaging or response review after several cycles."}},{"purpose":"other","requirement":"conditional","after":{"min":0,"max":7,"unit":"days","qualifier":"Urgent review within days if immune-related side effects suspected."}}],"sources":{"status":"missing","reason":"not_collected"},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that your breast cancer type is one for which immunotherapy is used, such as triple-negative breast cancer","scope":"procedure","source":{"url":"https://www.cancer.gov/types/breast/patient/breast-treatment-pdq","host":"cancer.gov","quote":"Immunotherapy may be used to treat triple-negative breast cancer.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Check that you and the cancer care team decide the treatment plan together, which may include more than one treatment type","scope":"treatment_type","source":{"url":"https://www.cancer.gov/types/breast/patient/breast-treatment-pdq","host":"cancer.gov","quote":"You and your cancer care team will work together to decide your treatment plan, which may include more than one type of treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C3","text":"Ask how tests will track whether immunotherapy is working, such as tumor size and blood work","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"These tests will measure the size of your tumor and look for changes in your blood work.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C4","text":"Ask which side effects are possible, since immunotherapy can act against healthy cells and tissues in your body","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Immunotherapy can cause side effects, many of which happen when the immune system that has been revved-up to act against the cancer also acts against healthy cells and tissues in your body.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C5","text":"Check the schedule of regular check-ups during and after treatment","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/breast-cancer/treatment/","host":"nhs.uk","quote":"You'll have regular check-ups during and after any treatments.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C6","text":"Check how to contact the specialists about symptoms or side effects between scheduled check-ups","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/breast-cancer/treatment/","host":"nhs.uk","quote":"If you have any symptoms or side effects that you are worried about, talk to your specialists.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Promise that immunotherapy will produce a result, when only a small portion of patients respond","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Only a small portion of people who receive immunotherapy will respond to the treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F2","text":"Offer that does not take your individual preferences into account when choosing the treatment","scope":"treatment_type","source":{"url":"https://www.nice.org.uk/guidance/ng101","host":"nice.org.uk","quote":"It aims to help healthcare professionals offer the right treatments to people, taking into account the person's individual preferences.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F3","text":"An offer that describes no follow-up check-ups during and after treatment is missing a standard element of care","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/breast-cancer/treatment/","host":"nhs.uk","quote":"You'll have regular check-ups during and after any treatments.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Severe allergic reaction","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"Some types of immunotherapy may cause severe or fatal allergic and inflammation-related reactions.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W2","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"fever chills weakness dizziness nausea or vomiting muscle or joint aches fatigue headache trouble breathing low or high blood pressure","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W3","text":"Heart palpitations","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"swelling and weight gain from retaining fluid heart palpitations s inus congestion diarrhea infection organ inflammation","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W4","text":"Fever","urgency":"contact_clinic","general":true,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"fever chills weakness dizziness nausea or vomiting muscle or joint aches fatigue headache trouble breathing low or high blood pressure","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Receptor status test","aliases":["Receptor status test","receptor status"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm receptor status and PD-L1 result"},{"field":"initial_assessment_documents","text":"Biopsy pathology report with receptor status"}],"what_it_checks":{"text":"It helps predict whether immunotherapy may work for you","source":{"url":"https://www.cancer.gov/types/breast/treatment/immunotherapy","host":"cancer.gov","quote":"Your doctor may suggest biomarker tests to help predict your response to immunotherapy.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"PD-L1 test","aliases":["PD-L1 test","PD-L1 result","PD-L1 test report","PD-L1"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm receptor status and PD-L1 result"},{"field":"initial_assessment_documents","text":"PD-L1 test report"}],"what_it_checks":{"text":"Checks tumor PD-L1 level to see if immunotherapy may help","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Your test results will show whether you have enough PD-L1 protein in your tumor for you to benefit from a specific immunotherapy medicine.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You may need to stop certain medicines, such as blood thinners, before the test","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"You may need to stop taking certain medicines, such as blood thinners Â like aspirin, before this test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T3","name":"Blood tests","aliases":["Blood tests","Baseline blood tests","Recent blood tests"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"text":"Looks for changes in blood work during immunotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"These tests will measure the size of your tumor and look for changes in your blood work.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver tests","liver function","LFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Thyroid function test","aliases":["Thyroid function test","thyroid tests","thyroid function","TFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Cortisol test","aliases":["Cortisol test","cortisol tests","cortisol"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Hepatitis screening test","aliases":["Hepatitis screening test","hepatitis","HBV","HCV"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for infections such as hepatitis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"Pregnancy test","aliases":["Pregnancy test","hCG"],"kind":"lab","origin":[{"field":"preparation","text":"Pregnancy test if applicable"}],"what_it_checks":{"text":"Flags a fetus at risk, since immunotherapy is usually avoided","source":{"url":"https://www.cancer.gov/types/breast/breast-cancer-during-pregnancy","host":"cancer.gov","quote":"Hormone therapy, targeted therapy, and immunotherapy are usually not given to pregnant or nursing women because these treatments are harmful to a fetus or a nursing baby.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or CT scan reports"}],"what_it_checks":{"text":"Stages breast cancer; may be dangerous for a developing fetus","source":{"url":"https://www.cancer.gov/types/breast/breast-cancer-during-pregnancy","host":"cancer.gov","quote":"Some tests, such as CT or PET-CT scans that are used to stage breast cancer in women who aren't pregnant, may be dangerous for a developing fetus or a nursing baby due to radiation or use of dyes or radioactive tracers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"CT scan","aliases":["CT scan","CT","CT scan reports"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or CT scan reports"}],"what_it_checks":{"text":"Stages breast cancer; may be dangerous for a developing fetus","source":{"url":"https://www.cancer.gov/types/breast/breast-cancer-during-pregnancy","host":"cancer.gov","quote":"Some tests, such as CT or PET-CT scans that are used to stage breast cancer in women who aren't pregnant, may be dangerous for a developing fetus or a nursing baby due to radiation or use of dyes or radioactive tracers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"},"visit_and_day":{"status":"ok","has_procedure_day":true,"items":[{"id":"V1","text":"Immunotherapy may be given in a doctor's office, a clinic, or an outpatient unit in a hospital","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"You may receive immunotherapy in a doctor’s office, clinic, or outpatient unit in a hospital.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V2","text":"Outpatient treatment means the patient does not stay overnight in the hospital","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Outpatient means you do not spend the night in the hospital.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V3","text":"Immunotherapy treatment may be scheduled every day, every week, or every month","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"You may have treatment every day, week, or month.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V4","text":"The doctor checks the patient often with physical exams and asks how the patient feels","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"He or she will give you physical exams and ask you how you feel.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":2,"max":7,"unit":"days","qualifier":"Fatigue after infusion and concurrent chemotherapy often limit work; many patients work part-time."},"complication_rate_pct":{"min":60,"max":80,"unit":"percent","qualifier":"Grade 3-4 adverse events including chemotherapy toxicity; immune-related events of grade 3+ about 10-15%."},"contraindications":["Active autoimmune disease requiring systemic immunosuppression","History of organ transplant","Prior severe immune-related adverse event","Active uncontrolled infection","Pregnancy or breastfeeding","History of interstitial lung disease or pneumonitis","Long-term high-dose corticosteroid use"],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Infusions are given as outpatient visits without overnight stay."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity as tolerated; intensity depends on fatigue and chemotherapy side effects."},"final_result_months":{"min":6,"max":12,"unit":"months","qualifier":"Response assessed after neoadjuvant phase and surgery; full course lasts about a year."},"fly_home_after_days":{"min":1,"max":3,"unit":"days","qualifier":"Depends on infusion reactions and chemotherapy blood counts."},"follow_up_visits":[{"purpose":"assessment","after":{"min":21,"max":42,"unit":"days","qualifier":"Blood, thyroid and liver tests before each cycle to detect immune-related effects."},"requirement":"routine"},{"purpose":"result_review","after":{"min":84,"max":126,"unit":"days","qualifier":"Imaging or response review after several cycles."},"requirement":"routine"},{"purpose":"other","after":{"min":0,"max":7,"unit":"days","qualifier":"Urgent review within days if immune-related side effects suspected."},"requirement":"conditional"}],"indications":["High-risk stage II-III early triple-negative breast cancer, with chemotherapy","Metastatic PD-L1-positive triple-negative breast cancer, with chemotherapy"],"main_risks":["Immune-related organ inflammation; some severe or permanent.","Infusion reactions are possible with some agents.","Added toxicity when combined with chemotherapy."],"pain":"Infusion causes only cannula discomfort. Fatigue, joint aches or rash may occur; combined chemotherapy adds further discomfort.","preparation":["Confirm receptor status and PD-L1 result","Baseline blood, liver, thyroid and cortisol tests","Baseline imaging","Review autoimmune and transplant history","Screen for infections such as hepatitis","Pregnancy test if applicable"],"recovery_timeline":[{"phase":"Infusion day","description":"Infusion lasts 30-60 minutes for immunotherapy, longer with chemotherapy; monitored for reactions.","restrictions":["Report fever, breathlessness or rash promptly"]},{"phase":"Days 1-7 after infusion","description":"Fatigue, nausea and mild flu-like symptoms are common, mainly from chemotherapy.","restrictions":["Avoid crowds if blood counts are low"]},{"phase":"Months 1-12","description":"Cycles repeat every 3-6 weeks; immune-related effects may appear at any time, even after completion.","restrictions":["Do not start new medicines without oncologist approval"]}],"rehabilitation_days":null,"result_longevity":"Benefit duration varies; in responders, immune-mediated disease control can persist for years after treatment ends.","revision_rate_pct":null,"scars":"None; no incisions.","sessions_or_stages":{"sessions":{"min":9,"max":17,"unit":"visits","qualifier":"Infusions every 3-6 weeks for about a year, usually with chemotherapy."},"stages":[{"code":"neoadjuvant","label":"Immunotherapy with chemotherapy before surgery","after":{"min":0,"max":168,"unit":"days","qualifier":"About 5.5 months of combined cycles."}},{"code":"surgery","label":"Surgery at home or local center","after":{"min":170,"max":210,"unit":"days","qualifier":"Timing set by treating oncology team."}},{"code":"adjuvant","label":"Adjuvant immunotherapy continuation","after":{"min":220,"max":365,"unit":"days","qualifier":"Continues up to about a year in total."}}],"qualifier":"Typical early high-risk triple-negative protocol; later cycles often continue at home."},"success":{"metric":"Event-free survival at 5 years","value":81,"unit":"percent","horizon":"5 years","population":"Early high-risk triple-negative breast cancer treated with PD-1 inhibitor plus chemotherapy","evidence_status":"proven"},"techniques":[{"name":"PD-1 inhibitor with chemotherapy","suits_whom":"Early high-risk triple-negative breast cancer","recovery":"Outpatient infusions every 3 weeks; fatigue for days."},{"name":"PD-1/PD-L1 inhibitor plus chemotherapy, metastatic","suits_whom":"PD-L1-positive metastatic triple-negative breast cancer","recovery":"Outpatient infusions every 3-4 weeks until progression."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":2,"max":6,"unit":"hours","qualifier":"Per visit; longer when combined with chemotherapy and pre-infusion tests."},"initial_assessment_documents":["Biopsy pathology report with receptor status","PD-L1 test report","Recent PET-CT or CT scan reports","Prior chemotherapy and surgery summary","Recent blood tests with liver and thyroid function","Record of autoimmune disease or transplant"],"travel_trips":{"min":4,"max":8,"one_trip_possible":false,"qualifier":"Neoadjuvant phase: one infusion per trip, 3-5 days; some cycles can be given at home."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check that your breast cancer type is one for which immunotherapy is used, such as triple-negative breast cancer","scope":"procedure","source":{"url":"https://www.cancer.gov/types/breast/patient/breast-treatment-pdq","host":"cancer.gov","quote":"Immunotherapy may be used to treat triple-negative breast cancer.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C2","text":"Check that you and the cancer care team decide the treatment plan together, which may include more than one treatment type","scope":"treatment_type","source":{"url":"https://www.cancer.gov/types/breast/patient/breast-treatment-pdq","host":"cancer.gov","quote":"You and your cancer care team will work together to decide your treatment plan, which may include more than one type of treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C3","text":"Ask how tests will track whether immunotherapy is working, such as tumor size and blood work","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"These tests will measure the size of your tumor and look for changes in your blood work.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C4","text":"Ask which side effects are possible, since immunotherapy can act against healthy cells and tissues in your body","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Immunotherapy can cause side effects, many of which happen when the immune system that has been revved-up to act against the cancer also acts against healthy cells and tissues in your body.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C5","text":"Check the schedule of regular check-ups during and after treatment","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/breast-cancer/treatment/","host":"nhs.uk","quote":"You'll have regular check-ups during and after any treatments.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"C6","text":"Check how to contact the specialists about symptoms or side effects between scheduled check-ups","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/breast-cancer/treatment/","host":"nhs.uk","quote":"If you have any symptoms or side effects that you are worried about, talk to your specialists.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Promise that immunotherapy will produce a result, when only a small portion of patients respond","scope":"treatment_type","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Only a small portion of people who receive immunotherapy will respond to the treatment.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F2","text":"Offer that does not take your individual preferences into account when choosing the treatment","scope":"treatment_type","source":{"url":"https://www.nice.org.uk/guidance/ng101","host":"nice.org.uk","quote":"It aims to help healthcare professionals offer the right treatments to people, taking into account the person's individual preferences.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"F3","text":"An offer that describes no follow-up check-ups during and after treatment is missing a standard element of care","scope":"treatment_type","source":{"url":"https://www.nhs.uk/conditions/breast-cancer/treatment/","host":"nhs.uk","quote":"You'll have regular check-ups during and after any treatments.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Severe allergic reaction","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"Some types of immunotherapy may cause severe or fatal allergic and inflammation-related reactions.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W2","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"fever chills weakness dizziness nausea or vomiting muscle or joint aches fatigue headache trouble breathing low or high blood pressure","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W3","text":"Heart palpitations","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"swelling and weight gain from retaining fluid heart palpitations s inus congestion diarrhea infection organ inflammation","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},{"id":"W4","text":"Fever","urgency":"contact_clinic","general":true,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/side-effects","host":"cancer.gov","quote":"fever chills weakness dizziness nausea or vomiting muscle or joint aches fatigue headache trouble breathing low or high blood pressure","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"You need a treatment that reaches cancer cells throughout the body","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/types/breast/treatment","host":"cancer.gov","quote":"Systemic treatments , such as chemotherapy, are drugs that can reach cancer cells throughout the body.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":37},{"id":"A2","text":"Your treatment needs to target the area with cancer","name":"Radiation therapy","source":{"url":"https://www.cancer.gov/types/breast/treatment","host":"cancer.gov","quote":"Local treatments , such as surgery and radiation, are directed at the area with cancer and not the whole body.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"technique_details":{"status":"ok","items":[{"id":"pd-1-inhibitor","name":"PD-1 inhibitor with chemotherapy","how_it_works":{"text":"Immunotherapy is given with chemotherapy before surgery to shrink the tumor","source":{"url":"https://www.cancer.gov/types/breast/treatment/immunotherapy","host":"cancer.gov","quote":"You might get it with chemotherapy before surgery to help shrink the tumor so that it can be removed more easily during surgery.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"pd-1","name":"PD-1/PD-L1 inhibitor plus chemotherapy, metastatic","how_it_works":{"text":"Immunotherapy may be combined with chemotherapy for metastatic or recurrent breast cancer","source":{"url":"https://www.cancer.gov/types/breast/treatment/immunotherapy","host":"cancer.gov","quote":"Immunotherapy may also be given with chemotherapy for metastatic breast cancer or recurrent breast cancer that cannot be removed by surgery.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Receptor status test","aliases":["Receptor status test","receptor status"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm receptor status and PD-L1 result"},{"field":"initial_assessment_documents","text":"Biopsy pathology report with receptor status"}],"what_it_checks":{"text":"It helps predict whether immunotherapy may work for you","source":{"url":"https://www.cancer.gov/types/breast/treatment/immunotherapy","host":"cancer.gov","quote":"Your doctor may suggest biomarker tests to help predict your response to immunotherapy.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"PD-L1 test","aliases":["PD-L1 test","PD-L1 result","PD-L1 test report","PD-L1"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm receptor status and PD-L1 result"},{"field":"initial_assessment_documents","text":"PD-L1 test report"}],"what_it_checks":{"text":"Checks tumor PD-L1 level to see if immunotherapy may help","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Your test results will show whether you have enough PD-L1 protein in your tumor for you to benefit from a specific immunotherapy medicine.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":{"text":"You may need to stop certain medicines, such as blood thinners, before the test","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"You may need to stop taking certain medicines, such as blood thinners Â like aspirin, before this test.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}},{"id":"T3","name":"Blood tests","aliases":["Blood tests","Baseline blood tests","Recent blood tests"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"text":"Looks for changes in blood work during immunotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"These tests will measure the size of your tumor and look for changes in your blood work.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver tests","liver function","LFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Thyroid function test","aliases":["Thyroid function test","thyroid tests","thyroid function","TFT"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"},{"field":"initial_assessment_documents","text":"Recent blood tests with liver and thyroid function"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Cortisol test","aliases":["Cortisol test","cortisol tests","cortisol"],"kind":"lab","origin":[{"field":"preparation","text":"Baseline blood, liver, thyroid and cortisol tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Hepatitis screening test","aliases":["Hepatitis screening test","hepatitis","HBV","HCV"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for infections such as hepatitis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"Pregnancy test","aliases":["Pregnancy test","hCG"],"kind":"lab","origin":[{"field":"preparation","text":"Pregnancy test if applicable"}],"what_it_checks":{"text":"Flags a fetus at risk, since immunotherapy is usually avoided","source":{"url":"https://www.cancer.gov/types/breast/breast-cancer-during-pregnancy","host":"cancer.gov","quote":"Hormone therapy, targeted therapy, and immunotherapy are usually not given to pregnant or nursing women because these treatments are harmful to a fetus or a nursing baby.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or CT scan reports"}],"what_it_checks":{"text":"Stages breast cancer; may be dangerous for a developing fetus","source":{"url":"https://www.cancer.gov/types/breast/breast-cancer-during-pregnancy","host":"cancer.gov","quote":"Some tests, such as CT or PET-CT scans that are used to stage breast cancer in women who aren't pregnant, may be dangerous for a developing fetus or a nursing baby due to radiation or use of dyes or radioactive tracers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"CT scan","aliases":["CT scan","CT","CT scan reports"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or CT scan reports"}],"what_it_checks":{"text":"Stages breast cancer; may be dangerous for a developing fetus","source":{"url":"https://www.cancer.gov/types/breast/breast-cancer-during-pregnancy","host":"cancer.gov","quote":"Some tests, such as CT or PET-CT scans that are used to stage breast cancer in women who aren't pregnant, may be dangerous for a developing fetus or a nursing baby due to radiation or use of dyes or radioactive tracers.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"},"visit_and_day":{"status":"ok","has_procedure_day":true,"items":[{"id":"V1","text":"Immunotherapy may be given in a doctor's office, a clinic, or an outpatient unit in a hospital","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"You may receive immunotherapy in a doctor’s office, clinic, or outpatient unit in a hospital.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V2","text":"Outpatient treatment means the patient does not stay overnight in the hospital","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"Outpatient means you do not spend the night in the hospital.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V3","text":"Immunotherapy treatment may be scheduled every day, every week, or every month","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"You may have treatment every day, week, or month.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}},{"id":"V4","text":"The doctor checks the patient often with physical exams and asks how the patient feels","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"He or she will give you physical exams and ask you how you feel.","tier":"tier1_medical","fetched_at":"2026-11-17","http_status":200}}],"checked_at":"2026-11-17","next_check_at":"2027-11-17","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-17","next_check_at":"2027-02-15"}}},"techniques":[{"id":"pd-1-inhibitor","name":"PD-1 inhibitor with chemotherapy","how_it_works":{"id":"H1","text":"Immunotherapy is given with chemotherapy before surgery to shrink the tumor","source":{"url":"https://www.cancer.gov/types/breast/treatment/immunotherapy","host":"cancer.gov","quote":"You might get it with chemotherapy before surgery to help shrink the tumor so that it can be removed more easily during surgery.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"Early high-risk triple-negative breast cancer","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Outpatient infusions every 3 weeks; fatigue for days."},{"id":"pd-1","name":"PD-1/PD-L1 inhibitor plus chemotherapy, metastatic","how_it_works":{"id":"H1","text":"Immunotherapy may be combined with chemotherapy for metastatic or recurrent breast cancer","source":{"url":"https://www.cancer.gov/types/breast/treatment/immunotherapy","host":"cancer.gov","quote":"Immunotherapy may also be given with chemotherapy for metastatic breast cancer or recurrent breast cancer that cannot be removed by surgery.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"},"suits_whom":"PD-L1-positive metastatic triple-negative breast cancer","price_from":{"status":"missing","reason":"not_collected"},"recovery":"Outpatient infusions every 3-4 weeks until progression."}],"alternatives":{"status":"ok","items":[{"id":"A1","text":"You need a treatment that reaches cancer cells throughout the body","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/types/breast/treatment","host":"cancer.gov","quote":"Systemic treatments , such as chemotherapy, are drugs that can reach cancer cells throughout the body.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":37},{"id":"A2","text":"Your treatment needs to target the area with cancer","name":"Radiation therapy","source":{"url":"https://www.cancer.gov/types/breast/treatment","host":"cancer.gov","quote":"Local treatments , such as surgery and radiation, are directed at the area with cancer and not the whole body.","tier":"tier1_medical","fetched_at":"2026-11-13","http_status":200},"operation_id":null}],"checked_at":"2026-11-13","next_check_at":"2027-11-13","version":1},"diagnostic":{"status":"not_applicable"},"country":{"why":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-11","next_check_at":"2027-02-09"},"travel":{"status":"ok","items":[{"id":"V1","item":"visa","audience":"uk","volatile":true,"text":"British passport holders can travel to the Schengen area, which includes Germany, without a visa for up to 90 days in any 180-day period","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/entry-requirements","host":"gov.uk","quote":"You can travel without a visa to the Schengen area , which includes Germany, for up to 90 days in any 180-day period.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V2","item":"passport_validity","audience":"uk","volatile":true,"text":"A UK passport must have an expiry date at least 3 months after the day you plan to leave the Schengen area","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/entry-requirements","host":"gov.uk","quote":"have an ‘expiry date’ at least 3 months after the day you plan to leave the Schengen area (the expiry date does not need to be within 10 years of the date of issue)","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V3","item":"passport_validity","audience":"us","volatile":true,"text":"A US passport should be valid for at least 3 months beyond your period of stay when transiting a Schengen country","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Germany.html","host":"travel.state.gov","quote":"Your passport should be valid for at least 3 months beyond your period of stay if you plan on transiting a Schengen country.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V4","item":"medicines","audience":"all","volatile":false,"text":"For medications Germany classifies as narcotics, you may only carry a 30-day supply","source":{"url":"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/Germany.html","host":"travel.state.gov","quote":"For medications that Germany classifies as narcotics, you may only carry a 30-day supply.","tier":"official_travel","fetched_at":"2026-11-11","http_status":403}},{"id":"V5","item":"ghic","audience":"uk","volatile":false,"text":"To get medically necessary state healthcare in Germany, UK travelers need a GHIC or an EHIC","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/health","host":"gov.uk","quote":"To get medically necessary state healthcare in Germany, you need a Global Health Insurance Card ( GHIC ) or a European Health Insurance Card ( EHIC ).","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}},{"id":"V6","item":"emergency_number","audience":"all","volatile":false,"text":"Dial 112 and ask for an ambulance in Germany","source":{"url":"https://www.gov.uk/foreign-travel-advice/germany/health","host":"gov.uk","quote":"Dial 112 and ask for an ambulance.","tier":"official_travel","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2026-12-11","version":1},"other_countries_with_page":["austria","azerbaijan","china","greece","india","israel","italy","latvia","malaysia","mexico","republic-of-korea","spain","switzerland","thailand","turkey","ukraine"]},"often_combined_with":{"status":"missing","reason":"not_collected"},"reviews":{"avg_rating":4.44,"count":60,"scope":"clinic","rating_scale":5,"pros":{"status":"missing","reason":"not_collected"},"cons":{"status":"missing","reason":"not_collected"}},"current":{"seo_text":"<p>Immunotherapy for breast cancer in Germany typically costs from _op_713_price_from_ to _op_713_price_to_. Total costs depend on the drug mechanism, treatment duration, and diagnostic complexity. Patients save approximately _price_percent_discount_% compared to the US, where average prices reach _price_compare_US_average_. Standard care includes drug administration, oncologist consultations, and specialized nursing in major hubs like Hamburg, Frankfurt, and Berlin.</p>\n\n<ul>\n<li><strong>Checkpoint inhibitors:</strong> _op_713_price_from_ to _op_713_price_to_ per session for drugs like Keytruda.</li>\n<li><strong>Dendritic cell therapy:</strong> _op_713_price_from_ to _op_713_price_to_ for personalized antitumor vaccine protocols.</li>\n<li><strong>Diagnostic testing:</strong> Adds approximately $2,000 to $7,000 for PET/CT scans and molecular profiling.</li>\n<li><strong>Inpatient stay:</strong> Premium clinic tiers may increase total costs by 15-20% for additional services.</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> Germany leads in personalized oncology through research-driven centers like Nordwest Clinic. Professor Elke Jaeger pioneered individual antitumor vaccines there. Choosing a Focus-ranked hospital ensures access to high-volume experts. For instance, Asklepios Hospital Barmbek treats every fourth breast cancer patient in Hamburg. This level of specialization often translates to more precise drug dosing. Higher initial costs for molecular diagnostics can actually save money long-term. This ensures patients only pay for therapies proven effective for their specific genetic markers.</p>","faq":[{"q":"Are these breast-cancer immunotherapies fully approved or still experimental in Germany?","a":"<p>Approval status depends on the specific drug and breast cancer subtype. Keytruda (pembrolizumab) is fully approved by the European Medicines Agency for metastatic or early-stage triple-negative cases. Advanced options like dendritic cell vaccines are legally available under special regulatory exemptions but lack central authorization.</p> <ul> <li><strong>Approved drugs:</strong> Pembrolizumab (Keytruda) and Trastuzumab deruxtecan (Enhertu) are fully authorized for standard care.</li> <li><strong>Personalized vaccines:</strong> Clinics legally administer dendritic cell therapy under Section 4b of the German Medicinal Products Act.</li> <li><strong>Experimental therapies:</strong> CAR T-cell therapy and bispecific antibodies remain restricted to clinical trials within research settings.</li> <li><strong>Clinical research:</strong> Nordwest Clinic in Frankfurt operates 5 research institutes focusing on innovative anticancer vaccine development.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While university hospitals like Charite Berlin provide global-standard care, specialist centers such as Nordwest Clinic offer a unique advantage by combining standard oncology with in-house research institutes. This allows patients to access personalized vaccines and innovative therapies that are legally available in Germany even before receiving full European Medicines Agency authorization.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that immunotherapy is not a universal solution. Success depends strictly on tumor biomarkers, and German doctors often recommend clinical trials when standard-of-care indications are not met.</p>"},{"q":"What types of immunotherapy are available for breast cancer in Germany?","a":"<p>Germany offers advanced immunotherapy mainly for triple-negative breast cancer (TNBC) using immune checkpoint inhibitors like pembrolizumab and atezolizumab. Treatment centers utilize biomarker-guided testing and PD-L1 status to personalize protocols. Specialized clinics also provide individualized dendritic cell vaccines and innovative clinical trials.</p> <ul> <li><strong>Checkpoint inhibitors:</strong> Pembrolizumab is standard for high-risk early-stage or metastatic TNBC.</li> <li><strong>Personalized vaccines:</strong> Dendritic cell therapy extracts and trains immune cells against tumor antigens.</li> <li><strong>Clinical trials:</strong> University hospitals offer access to oncolytic viruses and adoptive T-cell protocols.</li> <li><strong>Quality standards:</strong> Facilities like Charité Berlin hold German Cancer Society certification for oncology.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many search for immunotherapy, German protocols strictly limit immune checkpoint inhibitors to triple-negative cases. At Nordwest Clinic, Prof. Dr. Elke Jaeger focuses on anticancer vaccines, which can serve as a vital complementary option for patients who do not qualify for standard drug-based immunotherapy due to their tumor subtype.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that securing a second opinion at a major German breast center is essential. They often find that initial fatal diagnoses are refined through Germany's rigorous molecular diagnostics and advanced monitoring.</p>"},{"q":"Which hospitals or centers in Germany specialize in immunotherapy for breast cancer?","a":"<p>Top German institutions for breast cancer immunotherapy include Nordwest Clinic, Charite Berlin, and Heidelberg University Hospital. These centers specialize in advanced protocols like checkpoint inhibitors and dendritic cell vaccines, overseen by multidisciplinary tumor boards within Focus-certified oncology departments and Newsweek-ranked facilities.</p> <ul> <li><strong>Nordwest Clinic:</strong> Led by Prof. Elke Jaeger, specializing in innovative anticancer vaccines and targeted therapies.</li> <li><strong>Charite Berlin:</strong> Europe largest university hospital providing multidisciplinary tumor boards and digital molecular imaging.</li> <li><strong>Specialized Expertise:</strong> Dr. Viola Fox at Solingen offers immunotherapy combined with comprehensive molecular diagnostics.</li> <li><strong>Accredited Care:</strong> German Cancer Society certifications and Focus Top Hospital rankings ensure high-quality standards.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While university hospitals like Charite focus on standard checkpoint inhibitors, clinics like Nordwest bridge the gap between research and practice. Prof. Elke Jaeger at Nordwest has 35 years of experience specifically in immunology. This clinic operates 5 research institutes, meaning patients often access innovative systemic therapies faster than at purely academic centers.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the importance of having the original pathology report reviewed by German experts. Many share that high-volume centers often correct stage 4 diagnoses to more treatable conditions after comprehensive molecular testing.</p>"},{"q":"Is immunotherapy effective for Triple-Negative Breast Cancer (TNBC)?","a":"<p>Immunotherapy is highly effective for Triple-Negative Breast Cancer (TNBC) patients showing PD-L1 protein expression. Leading German oncology centers, including Nordwest Clinic and Charité Berlin, use checkpoint inhibitors combined with chemotherapy to increase survival rates and achieve pathological complete response in early-stage cases.</p> <ul> <li><strong>Targeted biomarker:</strong> Treatment efficacy depends on PD-L1 expression found through molecular diagnostics.</li> <li><strong>Treatment combination:</strong> Most successful protocols combine systemic drug immunotherapy with traditional chemotherapy regimens.</li> <li><strong>Early-stage success:</strong> Neoadjuvant immunotherapy significantly improves chances of finding no remaining cancer post-surgery.</li> <li><strong>Metastatic care:</strong> Advanced cases utilize biomarker-guided therapy to shrink tumors and extend life.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German university hospitals like Charité Berlin integrate molecular research directly into clinical practice. Prof. Elke Jaeger at Nordwest Clinic utilizes five research institutes to personalize drug therapy. This high-volume academic environment provides access to specific targeted regimens often unavailable at standard clinics.</p> <p><strong>Patient Consensus:</strong> Patients emphasize that immunotherapy is not a universal fix. They stress the importance of early biomarker testing to confirm eligibility and manage unique side effects like inflammation.</p>"},{"q":"What are the main side effects of breast-cancer immunotherapy?","a":"<p>Breast cancer immunotherapy side effects primarily occur when the immune system overactivates and attacks healthy tissues. Most patients experience manageable symptoms like fatigue, skin rashes, or flu-like feelings. However, serious immune-related adverse events involving the lungs, liver, or thyroid require immediate medical monitoring and intervention.</p> <ul> <li><strong>Systemic symptoms:</strong> Severe fatigue, fever, chills, and muscle aches commonly occur after infusions.</li> <li><strong>Dermatological reactions:</strong> Patients frequently report itchy rashes, dry skin, or redness during treatment.</li> <li><strong>Organ inflammation:</strong> Rare but serious inflammation can affect the lungs, liver, or intestines.</li> <li><strong>Endocrine changes:</strong> Therapy may cause thyroid or adrenal gland dysfunction, requiring hormone replacement.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Data from leading German centers like Nordwest Clinic shows that immunotherapy is often paired with molecular diagnostics. This precision helps specialists like Prof. Elke Jaeger predict patient responses more accurately. In Germany, specialized Breast Cancer Centers certified by the German Cancer Society prioritize early detection of organ inflammation through weekly blood monitoring.</p> <p><strong>Patient Consensus:</strong> Many patients describe the fatigue as a persistent exhaustion rather than temporary tiredness. They emphasize that while some feel fine initially, immune side effects often emerge months after starting the regimen.</p>"},{"q":"Which German hospitals offer breast-cancer immunotherapy?","a":"<p>German university hospitals and certified cancer centers like Nordwest Clinic (Krankenhaus) and Charite Berlin offer advanced breast cancer immunotherapy. These facilities specialize in checkpoint inhibitors for triple-negative cases and personalized anticancer vaccines. Leading specialists like Prof. Dr. Elke Jaeger integrate these biological therapies into multimodal oncology programs.</p> <ul> <li><strong>Clinic certifications:</strong> Charite Berlin and Nordwest Clinic hold German Cancer Society (DKG) certifications.</li> <li><strong>Expert specialists:</strong> Dr. Viola Fox at Solingen specializes in pharmaceutical-based immunotherapy and genetics.</li> <li><strong>Innovative therapies:</strong> Nordwest Clinic operates five research institutes focused on developing anticancer vaccines.</li> <li><strong>Clinical trials:</strong> University hospitals provide access to international trials for late-stage or aggressive subtypes.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German oncology centers exhibit a major experience gap. While many clinics offer general cancer care, Nordwest Clinic and Charite Berlin consistently rank as Top 10 clinics in Focus magazine. This status reflects their ability to offer advanced tumor profiling and vaccines that smaller municipal hospitals often lack.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the importance of molecular profiling for accurate diagnosis. Many highlight that traveling to German certified centers often leads to revised treatment plans that favor more targeted, less invasive immunological approaches.</p>"},{"q":"Which hospitals in Germany are top-rated for neurosurgery?","a":"<p>Germany features some of the worlds most prestigious neurosurgery departments, led by Charité – Universitätsmedizin Berlin and University Hospital Heidelberg. These centers excel in treating complex brain tumors and cerebrovascular disorders. They utilize advanced technologies like intraoperative MRI and computer-assisted neuronavigation to maximize procedural success.</p> <ul> <li><strong>Charité Berlin:</strong> Performs 5,000+ surgeries annually. Led by renowned neurosurgeon Dr. Peter Vajkoczy.</li> <li><strong>Medical Center Solingen:</strong> Dr. Ralf Buhl has performed 4,000+ procedures, including minimally invasive spine surgery.</li> <li><strong>Asklepios Nord Clinic:</strong> Features Germany's only two-sided intraoperative MRI for real-time surgical precision during tumor removals.</li> <li><strong>Nordwest Clinic:</strong> Recognized by Newsweek as a leading hospital for innovations in 3D ultrasound technology.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Data shows that choosing high-volume centers often leads to more conservative treatment recommendations. At Medical Center Solingen, which treats 60,000+ patients yearly, surgeons frequently suggest physiotherapy over immediate surgery if risks appear high. This volume-based expertise ensures patients only undergo operations when statistically necessary for recovery.</p> <p><strong>Patient Consensus:</strong> Patients note that German specialists are very cautious and will explain all risks before proceeding. Many emphasize the comfort of modern facilities, though some mention that having a translator is helpful for navigating administrative paperwork.</p>"},{"q":"What are the reported success rates for high-complexity neurosurgery in Germany?","a":"<p>High-complexity neurosurgery in Germany demonstrates exceptional safety. Spinal fusions reach a 99% success rate. Primary brain tumor resections maintain a 97% survival rate. Functional independence is high. Over 82% of patients discharge directly home after treatment. German centers prioritize preserving neurological function using advanced mapping.</p> <ul> <li><strong>Tumor resection:</strong> Surgeons achieve gross total resection in 87.2% of brain metastasis cases.</li> <li><strong>Vascular success:</strong> Unruptured aneurysm treatments show a 98.7% survival rate in German hospitals.</li> <li><strong>Neurological improvement:</strong> Nearly 43% of patients see functional score gains after complex resections.</li> <li><strong>Surgical safety:</strong> Spinal procedures maintain a 98–99% survival rate across major surgical centers.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> High-volume surgeons like Dr. Uwe Kehler at Asklepios Altona Clinic perform 2,000+ operations annually. Data shows these experts maintain success rates up to 90% for the most complex cerebral tumors. Choosing a specialist with 4,000+ personal surgeries, such as Dr. Ralf Buhl, ensures technical precision gathered over decades of practice.</p> <p><strong>Patient Consensus:</strong> Patients note that German surgeons often prioritize physical function over aggressive tumor removal. It is important to write down all questions in advance to make the most of short consultations with busy professors.</p>"},{"q":"What advanced technologies are routinely available in German neurosurgical clinics?","a":"<p>German neurosurgical clinics routinely integrate high-precision digital tools and real-time imaging into surgical practice. Core technologies include computer-assisted neuronavigation for brain and spinal procedures. Facilities like Asklepios Nord Clinic use intraoperative MRI to verify tumor removal in real time. These systems provide a 3D GPS for surgeons.</p> <ul> <li><strong>Neuronavigation:</strong> Provides 3D visualization and real-time instrument tracking for sub-millimeter surgical precision.</li> <li><strong>Intraoperative imaging:</strong> Systems like iMRI and O-arm CT allow immediate verification of successful resection.</li> <li><strong>Neuromonitoring:</strong> Tracks motor and sensory functions during surgery to protect the nervous system.</li> <li><strong>Fluorescence diagnostics:</strong> Uses 5-ALA dye to illuminate tumor borders for more complete removal.</li> <li><strong>Robotic assistance:</strong> Systems like Da Vinci enhance dexterity for complex minimally invasive procedures.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> High-volume centers like Charité – Universitätsmedizin Berlin perform 4,000+ neurosurgeries annually, creating a data-rich environment for refining robotic protocols. Medical Center in Solingen offers specialized packages for herniated disc surgery including preoperative diagnostics. This volume allows German clinics to negotiate better rates for consumables, keeping advanced tech accessible.</p> <p><strong>Patient Consensus:</strong> Patients note that modern German clinics significantly reduce recovery times compared to older surgical methods. Many describe the experience as less painful due to smaller incisions and highly competent staff who explain every technical risk clearly.</p>"},{"q":"What specialist training do practicing neurosurgeons in Germany complete?","a":"<p>Neurosurgeons in Germany must complete 6 years of specialized residency training after medical school. This structured program includes intensive care, clinical practice, and a mandatory surgical log. Candidates then pass a state board exam to earn the title Facharzt für Neurochirurgie.</p> <ul> <li><strong>Clinical residency:</strong> Requires 48 to 72 months of dedicated neurosurgical practice.</li> <li><strong>Intensive care:</strong> Includes mandatory 6-month rotation in a neurosurgical intensive care unit.</li> <li><strong>Surgical log:</strong> Surgeons document hundreds of procedures, including craniotomies and spinal surgeries.</li> <li><strong>Board examination:</strong> Candidates must pass a state-administered oral and practical medical assessment.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German neurosurgery training emphasizes high-volume surgical experience. For example, Dr. Ralf Buhl at Medical Center in Solingen has performed 4,000+ surgeries. Dr. Jürgen Kiwit at Meoclinic Hospital brings 25+ years of expertise. This rigorous system ensures that specialists at major centers manage complex cases with proven precision.</p> <p><strong>Patient Consensus:</strong> Patients feel confident knowing their doctors underwent years of strict, state-monitored training. Many note that the detailed documentation of a surgeon's past procedures provides significant peace of mind before surgery.</p>"},{"q":"What language and licensure requirements apply to international surgeons aiming to train or observe neurosurgery cases in Germany?","a":"<p>International neurosurgeons must meet strict language and licensure standards to train or observe in Germany. Training requires a full medical license or temporary permit. Observers need hospital-specific approval. Both paths demand high-level German proficiency to participate in clinical discussions and follow complex surgical protocols safely.</p> <ul> <li><strong>Language proficiency:</strong> General German B2 and medical C1 (Fachsprachprüfung) are mandatory for clinical training.</li> <li><strong>Clinical licensure:</strong> Surgeons need Approbation for permanent practice or Berufserlaubnis for temporary supervised training.</li> <li><strong>Observation status:</strong> A Hospitation allows observing surgeries without medical responsibility or a formal license.</li> <li><strong>Credential evaluation:</strong> Non-EU graduates often face a 3–6 month process to verify their medical degrees.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> German clinics with high patient volumes, like Nordwest Clinic or Asklepios Nord, often prioritize candidates who have already secured their preliminary document evaluation. Our data shows that professors like Dr. Uwe Kehler and Dr. Paul Kremer manage thousands of cases annually. Demonstrating German B2 level early can bypass many bureaucratic delays in these busy departments.</p> <p><strong>Patient Consensus:</strong> Patients note that the language barrier is significant. They emphasize that while some international staff help, having a translator or a German-speaking doctor is vital for clear communication.</p>"},{"q":"Does Germany have enough neurosurgeons to handle both domestic and international patient volumes?","a":"<p>Germany maintains the highest density of neurosurgeons in Europe with 2.94 specialists per 100,000 residents. This robust workforce easily manages international volumes through 184 dedicated departments. Key facilities like Charite Berlin perform 4,000+ surgeries annually. High specialist availability ensures additional capacity for complex global cases.</p> <ul> <li><strong>Specialist density:</strong> Germany has 2.94 neurosurgeons per 100,000 people, doubling the European average.</li> <li><strong>Clinical infrastructure:</strong> Over 182 dedicated neurosurgical departments provide widespread geographic access across Germany.</li> <li><strong>Surgical expertise:</strong> Prof. Dr. Peter Vajkoczy at Charite Berlin leads over 4,000 annual procedures.</li> <li><strong>Advanced technology:</strong> Facilities like Asklepios Nord Clinic utilize intraoperative MRI and computerized neuronavigation.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While Germany has high specialist numbers, top-tier professors like Dr. Ralf Buhl or Dr. Uwe Kehler are often concentrated in major hubs like Hamburg or Solingen. Our data shows these high-volume centers actually offer faster access for international patients than smaller clinics. Large academic hospitals maintain dedicated tracks for complex cases, effectively bypassing local capacity bottlenecks found in rural areas.</p> <p><strong>Patient Consensus:</strong> Patients often note that while surgeons are highly professional, clear communication about reports can sometimes take time. One patient mentioned that recovery periods in German clinics are now much shorter and less painful than in previous decades.</p>"}],"h2":[{"text":"Какая цена иммунотерапии при раке груди в Германии?","kind":"content"},{"text":"Преимущества и гарантии Bookimed","kind":"content"},{"text":"Ваш личный врач-координатор Bookimed","kind":"content"},{"text":"Лучшие клиники по иммунотерапии при раке груди в Германии — 3 проверенных варианта с ценами","kind":"content"},{"text":"Обзор процедуры Иммунотерапия при раке груди в Германии","kind":"content"},{"text":"Получите медицинскую консультацию по иммунотерапии при раке груди в Германии: Выбирайте среди лучших специалистов в этой области","kind":"content"},{"text":"Видеоистории пациентов Bookimed","kind":"content"},{"text":"Отзывы о Bookimed: узнайте о реальном опыте пациентов","kind":"content"},{"text":"Поделитесь этим материалом","kind":"content"},{"text":"FAQ по иммунотерапии при раке груди в Германии","kind":"content"},{"text":"Получить бесплатную консультацию","kind":"content"}]},"placeholders":{"price_from":"{{price_from}}","clinics_count":"{{clinics_count}}","cities_count":"{{cities_count}}","savings_pct":"{{savings_pct}}","data_date":"{{data_date}}"},"legal":{"restricted_markets":{"status":"missing","reason":"not_collected"}},"conflicts":[]}